Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches
dc.contributor.author | Manyelo, Charles M. | en_ZA |
dc.contributor.author | Solomons, Regan S. | en_Za |
dc.contributor.author | Walzl, Gerhard | en_ZA |
dc.contributor.author | Chegou, Novel N. | en_ZA |
dc.date.accessioned | 2023-03-24T12:41:20Z | en_ZA |
dc.date.available | 2023-03-24T12:41:20Z | en_ZA |
dc.date.issued | 2021-02 | en_ZA |
dc.description | CITATION: Manyelo CM, Solomons RS, Walzl G, Chegou NN. 2021. Tuberculous meningitis: pathogenesis, immune responses, diagnostic challenges, and the potential of biomarker-based approaches. J Clin Microbiol 59:e01771-20. doi.10.1128/JCM.01771-20. | en_ZA |
dc.description | The original publication is available at: asm.org | en_ZA |
dc.description.abstract | Tuberculous meningitis (TBM) is the most devastating form of tuberculosis (TB), causing high mortality or disability. Clinical management of the disease is challenging due to limitations of the existing diagnostic approaches. Our knowledge on the immunology and pathogenesis of the disease is currently limited. More research is urgently needed to enhance our understanding of the immunopathogenesis of the disease and guide us toward the identification of targets that may be useful for vaccines or host-directed therapeutics. In this review, we summarize the current knowledge about the immunology and pathogenesis of TBM and summarize the literature on existing and new, especially biomarker-based, approaches that may be useful in the management of TBM. We identify research gaps and provide directions for research which may lead to the development of new tools for the control of the disease in the near future. | en_ZA |
dc.description.version | Publisher’s version | en_ZA |
dc.format.extent | 16 pages | en_ZA |
dc.identifier.citation | Manyelo CM, Solomons RS, Walzl G, Chegou NN. 2021. Tuberculous meningitis: pathogenesis, immune responses, diagnostic challenges, and the potential of biomarker-based approaches. J Clin Microbiol 59:e01771-20. doi.10.1128/JCM.01771-20. | en_ZA |
dc.identifier.issn | 0095-1137 (print) | en_ZA |
dc.identifier.issn | 1098-660X (online) | en_ZA |
dc.identifier.other | doi.10.1128/JCM.01771-20. | en_ZA |
dc.identifier.uri | http://hdl.handle.net/10019.1/126712 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | American Society for Microbiology | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Meninges -- Tuberculosis | en_ZA |
dc.subject | Central nervous system -- Diseases | en_ZA |
dc.subject | Biochemical markers | en_ZA |
dc.subject | Immune response | en_ZA |
dc.subject | Meninges -- Pathogenesis | en_ZA |
dc.title | Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches | en_ZA |
dc.type | Article | en_ZA |